Digest Network Come funziona
Network
/
Società
Ne
Non verificato

Newleos Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VariePsichiatriaSalute

13 comunicati stampa

Guarda tutti i comunicati
03/11/2026
Industria
Psichiatria
Scienza
Igiene alimentare
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Newleos Announces $15.5 Million NIH Grant and Receipt of FDA Fast Track Designation for NTX-2001 to Treat Substance Use Disorders
Fonte
Newleos Therapeutics, Inc.
Emittente
Business Wire
1.00
0
28/07/2026
Newleos Names Rohan Palekar as Board Chairman
Fonte
Newleos Therapeutics, Inc.
Emittente
Business Wire
1.00
0
29/04/2026
Industria
Biotecnologia
Psichiatria
Salute
Farmaceutica
Medicina - Varie
Newleos Announces Dosing of First Participant in Phase 1b Study of NTX-2001 for Alcohol Use Disorder
Fonte
Newleos Therapeutics, Inc.
Emittente
Business Wire
1.00
0
01/04/2026
Biotecnologia
Psichiatria
Salute
Farmaceutica
Medicina - Varie
Newleos Announces Dosing of First Participant in U.K. Phase 1b Study of NTX-1955 in Generalized Anxiety Disorder
Fonte
Newleos Therapeutics, Inc.
Emittente
Business Wire
1.00
0
06/01/2026
Psichiatria
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
Newleos Therapeutics Announces Dosing of First Participant in SOAR Phase 2 Study of NTX-1472 for Social Anxiety Disorder
Fonte
Newleos Therapeutics, Inc.
Emittente
Business Wire
1.00
0
21/10/2025
Newleos Therapeutics Appoints Timothy Noyes as President and Chief Executive Officer
Fonte
Newleos Therapeutics, Inc.
Emittente
Business Wire
1.00
0
15/10/2025
Psichiatria
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Eventi
Newleos Therapeutics CEO David Donabedian Recognized by Goldman Sachs as One of the Most Exceptional Entrepreneurs at the 2025 Builders and Innovators Summit
Fonte
Newleos Therapeutics, Inc.
Emittente
Business Wire
1.00
0
30/09/2025
Psichiatria
Igiene alimentare
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
Newleos Therapeutics Announces Clinical Progress Across Neuropsychiatric Pipeline
Fonte
Newleos Therapeutics, Inc.
Emittente
Business Wire
1.00
0
09/09/2025
Psichiatria
Scienza
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Eventi
Industria
Newleos Therapeutics Announces Poster Presentation to be Featured at the 2025 World Congress of Biological Psychiatry
Fonte
Newleos Therapeutics, Inc.
Emittente
Business Wire
1.00
0
23/07/2025
Psichiatria
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Mercato del lavoro
Industria
Newleos Therapeutics Appoints Stephen Brannan to Board of Directors and Announces NTX-1955 Clinical Progress in Generalized Anxiety Disorder
Fonte
Newleos Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0